Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:HELP
NasdaqGM:HELPPharmaceuticals

Assessing Cybin (HELP) Valuation After HLP004 Phase 2 Anxiety Data Draws Fresh Attention

Cybin (HELP) drew fresh attention after Helus Pharma released topline Phase 2 data for HLP004 in generalized anxiety disorder, showing clinically meaningful symptom reductions, durable responder and remitter rates, and a favorable safety profile in difficult-to-treat patients. See our latest analysis for Cybin. Despite the strong HLP004 readout and recent news flow, including a Form 6-K filing and conference appearances, Cybin’s recent share price moves have been weak. The 7-day share price...
ENXTAM:BESI
ENXTAM:BESISemiconductor

Potential Hybrid Bonding Delay Tests BE Semiconductor Industries Growth Story

Industry discussions suggest leading memory makers may delay adopting BE Semiconductor Industries' hybrid bonding technology for next generation high bandwidth memory. Possible changes to package thickness standards are at the center of the debate, creating uncertainty around the timing of commercial rollout. The news comes as ENXTAM:BESI trades around €156.3, with the stock up 58.1% over the past year and 200.6% over five years. For investors following ENXTAM:BESI, the potential delay...
NZSE:FBU
NZSE:FBUBuilding

Fletcher Building (NZSE:FBU) Valuation Check After New 10 Year NZ Transport Agency Contracts

Event backdrop and why Fletcher Building is on the radar Fletcher Building (NZSE:FBU) is back in focus after subsidiary Higgins Contractors signed 10 year integrated delivery contracts with the New Zealand Transport Agency, while New Zealand shares have been soft amid rising Middle East related geopolitical risks. See our latest analysis for Fletcher Building. At a share price of NZ$3.45, Fletcher Building has had a 30 day share price return of 8.49% and a year to date share price return of...
NYSE:LION
NYSE:LIONEntertainment

Lionsgate Tests New IP Revenue Streams With Scentbird Fragrance Tie Ups

Lionsgate Studios, NYSE:LION, is partnering with Scentbird to launch limited-edition fragrances tied to The Twilight Saga and John Wick. The collaboration introduces exclusive scent drops that connect film IP with lifestyle products for fans. Campaigns feature social media activations, experiential marketing, and involvement from original cast members. Lionsgate Studios, NYSE:LION, has long leaned on franchises such as The Twilight Saga and John Wick as key entertainment assets, and this...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure Leans Into E Infrastructure As Valuation Premium Widens

Sterling Infrastructure (NasdaqGS:STRL) is accelerating its shift toward high-complexity E-Infrastructure work tied to AI data centers and semiconductor facilities. The company is prioritizing mission-critical projects for large technology clients, supported by a sizeable backlog and visibility into future phases of work. This pivot reduces Sterling's exposure to traditional construction and leans into long-term themes such as data center demand and domestic onshoring. Sterling...
BIT:PIA
BIT:PIAAuto

Piaggio And C (BIT:PIA) Margin Compression To 2.4% Tests Bullish Earnings Narrative

Piaggio & C (BIT:PIA) has laid out a steady set of FY 2025 numbers, with third quarter revenue of €351.8 million and basic EPS of €0.004. Earlier quarters saw revenue at €481.9 million with EPS of €0.061 in Q2, and €370.7 million with EPS of €0.025 in Q1. Over the trailing twelve months to the third quarter of 2025, revenue came in at about €1.5 billion with basic EPS of €0.104. This frames the latest quarter within a year of modest profitability, where net profit margins sit at 2.4% compared...
NasdaqCM:CMPX
NasdaqCM:CMPXBiotechs

A Look At Compass Therapeutics (CMPX) Valuation After Recent Trial Milestones And FDA Clearance

Clinical milestones and earnings set the context for Compass Therapeutics stock Compass Therapeutics (CMPX) has been in focus after reaching the planned survival event threshold in its Phase 2/3 COMPANION-002 trial for biliary tract cancer, along with FDA clearance for its CTX-10726 investigational program. These developments come as the company reported a full year 2025 net loss of US$66.49 million and a fourth quarter net loss of US$15.72 million, figures that help frame current...
NasdaqGS:VSNT
NasdaqGS:VSNTMedia

Versant Media Group (VSNT) Balances Buybacks, Dividend and Digital Pivot Is Capital Allocation Truly Aligned?

Versant Media Group, Inc. recently reported full-year 2025 results showing lower sales of about US$6.69 billion and net income of US$930 million, while its board approved a US$0.375 quarterly dividend and authorized up to US$1 billion in share repurchases. Alongside these capital return moves, management is emphasizing disciplined bolt-on acquisitions, a shift toward digital and ad-supported platforms, and maintaining a strong balance sheet as a newly independent media company. Next, we’ll...
NYSE:FVRR
NYSE:FVRRProfessional Services

Fiverr Downgrades And Investor Exit Test Confidence In Turnaround Story

Multiple analysts have downgraded Fiverr International (NYSE:FVRR), signaling a reset in sentiment around the platform's business outlook. The Optimist Fund, a major institutional investor and former top holder of FVRR, has fully exited its position. These moves come as the market focuses on Fiverr's customer acquisition challenges and pressure on active buyer trends and revenue expectations. For you as an investor, the reaction in NYSE:FVRR has been sharp. The stock closed at $11.33, with...
ENXTAM:ADYEN
ENXTAM:ADYENDiversified Financial

Adyen (ENXTAM:ADYEN) Maintains 44.7% Net Margin Challenging Bullish Expansion Narratives

Adyen (ENXTAM:ADYEN) has wrapped up FY 2025 with second half revenue of €1.3 billion and net income of €581.6 million, while the first half delivered €1.1 billion in revenue and €481.0 million in net income, setting a clear earnings season marker for the year. Over the past few reporting periods the company has seen revenue move from €1.1 billion in H2 2024 to €1.1 billion in H1 2025 and €1.3 billion in H2 2025, with trailing twelve month net income at €1.1 billion and EPS of €31.75. With a...
ASX:JIN
ASX:JINHospitality

Assessing Jumbo Interactive (ASX:JIN) Valuation After Mixed Half Year Earnings And Dividend Cut

Jumbo Interactive (ASX:JIN) has drawn fresh attention after releasing half year results to 31 December 2025, alongside a revised fully franked interim dividend of A$0.12 per share with an ex dividend date set for 3 March. See our latest analysis for Jumbo Interactive. The earnings announcement and trimmed interim dividend came after a weak stretch for Jumbo Interactive. The 90 day share price return of 19.55% and 1 year total shareholder return of 14.11% are both in decline, despite a 1 day...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

DOJ Probe Puts Regencell Bioscience Finances And Investor Outlook Under Strain

The U.S. Department of Justice has opened an investigation into Regencell Bioscience Holdings for potential violations of federal securities laws. Authorities have requested extensive documentation related to the company’s operations, finances, and accounting. Regencell expects substantial legal expenses and acknowledges the possibility of fines or settlements that may not be fully covered by insurance. For shareholders of Regencell Bioscience Holdings, ticker NasdaqCM:RGC, this...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

Is JOYY (JOYY) Pricing Reflect Its Strong DCF And P/E Signals?

If you are wondering whether JOYY's share price really reflects what the business is worth, you are not alone. This article is going to focus squarely on that question. JOYY recently closed at US$60.80, with returns of 1.9% over 7 days, a 1.8% decline over 30 days, a 6.1% decline year to date, a 33.8% gain over 1 year and a 139.0% gain over 3 years, while the 5 year return stands at a 36.6% decline. These mixed returns have kept investors focused on how sentiment around JOYY is shifting, and...
TSE:6201
TSE:6201Machinery

Toyota Industries Faces US Settlement And Activist Exit Turning Point

Toyota Industries faces a proposed US$299.5m class action settlement tied to emissions certification issues for Toyota IC Forklifts in the US. Elliott Investment Management has agreed to tender its shares after a revised buyout offer from Toyota Fudosan, effectively ending its activist campaign. These developments affect customers, governance and control at Toyota Industries, TSE:6201, and come as the company trades at ¥20,525.0 per share. Toyota Industries, TSE:6201, sits at the center of...
NYSE:APG
NYSE:APGConstruction

APi Group Leans On Inspection First Model To Build Cash And Scale

APi Group (NYSE:APG) reports record revenue levels alongside higher profitability. The company highlights 21 consecutive quarters of double digit inspection growth in North America. Management continues to pursue bolt on acquisitions while expanding free cash flow margins. APi Group, listed on the NYSE under the ticker APG, focuses on safety and specialty services with an inspection first model that aims to drive recurring revenue. Recent updates around record revenue, stronger...
NYSE:NOMD
NYSE:NOMDFood

Is Nomad Foods (NOMD) Starting To Look Interesting After A 47% One Year Share Price Slide

If you are wondering whether Nomad Foods at US$10.33 is starting to look like value or a value trap, you are not alone. That is exactly what this article will unpack. The stock has seen an 8.3% decline over the last week, an 18.0% drop over the past month, and is down 47.0% over the past year, putting long term holders under pressure and raising fresh questions about risk and return. Recent coverage has focused on how prolonged share price weakness and earlier acquisition activity have...
NasdaqCM:SPT
NasdaqCM:SPTSoftware

Sprout Social (SPT) Is Up 9.1% After Mixed Q4 Results and New 2026 Outlook – What’s Changed

Sprout Social recently reported fourth-quarter 2025 revenue of US$120.89 million and a net loss of US$10.74 million, alongside filing a US$23.19 million shelf registration for 3,573,414 Class A shares tied to its employee stock ownership plans. The combination of improving loss per share, new 2026 revenue guidance, and potential employee share issuance offers fresh insight into how Sprout Social is funding growth and rewarding staff while remaining unprofitable. Against this backdrop of...
ENXTAM:EXO
ENXTAM:EXODiversified Financial

Is Exor (ENXTAM:EXO) Offering An Opportunity After Its 23.1% Share Price Decline?

If you are wondering whether Exor's recent share price makes it a bargain or a value trap, you are in the right place to unpack what the current market price might be implying. The stock last closed at €71.45, with returns of 1.9% over 30 days but a 23.1% decline over the past year, which can change how investors think about both its growth potential and its risk profile. Recent news around Exor has focused on its role as a diversified financial holding company and how shifts in market...
NasdaqGS:TBLA
NasdaqGS:TBLAInteractive Media and Services

Taboola.com (TBLA) Valuation Check After Swing To Profit And New Revenue Guidance

Why Taboola.com (TBLA) is back on investor radar Taboola.com (NasdaqGS:TBLA) is in focus after reporting fourth quarter and full year 2025 results that shifted from a prior year net loss to net income, along with new 2026 revenue guidance. See our latest analysis for Taboola.com. The earnings release and fresh 2026 guidance have put Taboola.com back in focus, with a 1 day share price return of 6.92% and 7 day share price return of 11.11% contrasting with a weaker year to date share price...
NYSE:ACA
NYSE:ACAConstruction

Arcosa Refocuses On Infrastructure As Barge Sale Reshapes Earnings Story

Arcosa (NYSE:ACA) announced the sale of its barge business and is shifting its focus toward construction materials and engineered structures. The move is aimed at concentrating resources on U.S. infrastructure and power related businesses that management views as core to the company. Arcosa, trading at $111.28 at the last close, is coming off a strong longer term stretch, with the stock up 37.0% over the past year and 87.8% over three years. The company is also ahead 76.5% over five years,...
ASX:HZN
ASX:HZNOil and Gas

Does Horizon Oil (ASX:HZN) Prioritising Dividends Amid Softer Earnings Reveal Its True Capital Allocation Stance?

Horizon Oil Limited recently announced a dividend of A$0.015 per share for the six months ended December 31, 2025, alongside half-year results showing sales of US$44.64 million and net income of US$2.36 million, both lower than the same period a year earlier. The decision to maintain a dividend despite weaker earnings highlights management’s focus on ongoing cash returns to shareholders, even as profitability softens. We’ll now examine how Horizon Oil’s decision to pay this dividend despite...
NYSE:MPT
NYSE:MPTHealth Care REITs

Medical Properties Trust Faces Prospect Bankruptcy Test For Rent Resilience

Medical Properties Trust (NYSE:MPT) has issued a response to Prospect Medical Group's bankruptcy filing. The company is outlining potential operational impacts related to Prospect's tenant status and leased hospital assets. Investors are watching for updates on rental income exposure, asset utilization, and any changes to existing lease arrangements. Medical Properties Trust focuses on owning and leasing hospital and healthcare facilities, so any disruption involving a key tenant like...
NasdaqGS:AARD
NasdaqGS:AARDPharmaceuticals

A Look At Aardvark Therapeutics (AARD) Valuation After HERO Trial Pause And Volatile Share Price Moves

Aardvark Therapeutics (AARD) has put its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on hold after reversible cardiac issues at higher doses, triggering delays, legal scrutiny, and sharp share price swings. See our latest analysis for Aardvark Therapeutics. The HERO trial pause has been the clear driver of volatility, with Aardvark Therapeutics’ 1-day share price return of 15.1% coming after sharp declines, including a 57.6% 30-day share price loss and a 50.4% 1-year total...
ASX:NEC
ASX:NECMedia

Assessing Nine Entertainment Holdings’ Valuation After Profitability Jumps On Recent Half Year Earnings

Why Nine Entertainment Holdings (ASX:NEC) is Back on Investors’ Radar Nine Entertainment Holdings (ASX:NEC) has moved into the spotlight after its half year earnings update, where net income and earnings per share were far higher than the previous period despite softer sales. On the same day, the company also announced an ordinary dividend of A$0.045 per share for the six months to 31 December 2025, with an ex date of 9 March 2026 and payment scheduled for 23 April 2026. Together, these...